Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.
about
Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.Design and application of multifunctional DNA nanocarriers for therapeutic deliveryCancer vaccinesTowards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.Preclinical and clinical development of DNA vaccines for prostate cancer.DNA vaccines: developing new strategies against cancer.T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.DNA vaccines: ready for prime time?Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.Gene therapy of benign gynecological diseases.Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.Immunotherapy of cancer in 2012.The role of peptide and DNA vaccines in myeloid leukemia immunotherapyA phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.Trial watch: DNA vaccines for cancer therapy.Emerging cancer vaccines: the promise of genetic vectors.DNA Vaccines for Prostate Cancer.DNA vaccination: using the patient's immune system to overcome cancerInduction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.DNA vaccination for prostate cancer: key concepts and considerations.Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?DNA vaccines for prostate cancer.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
P2860
Q24813328-5F20FB56-C587-4ECD-BAB9-133DABB4FDC9Q27007011-1165FDA5-126D-476B-9F41-E7B5BD1440D6Q27024438-CD49F72C-1F21-4EB5-9071-199FEA20CF83Q30395754-04A83FAD-F27F-4478-896C-EA5C61C9D170Q33348633-D15E4E9F-B3BA-4D7C-9405-19E9A2C873B1Q33740811-027FD454-5220-40F1-8423-37BBE5A0EAE0Q33756622-B55E9C00-8C69-4482-B391-1CD78A74B895Q34577158-99292633-360E-4218-9842-67852F14DC89Q34610121-B554A30A-9760-479E-8803-AF58FD16BFB6Q34824179-8B35F3BD-0BB0-42ED-AB08-C12763CBC75CQ35218994-F3EC2CF2-FBE0-4BAA-BBC9-0F656A889CFBQ35758285-E05D15EA-09D0-43EF-B228-BF4F81AD3E89Q35770271-BF11CD7E-EEE1-4183-B934-9BAF9000EC0EQ35948223-D3CEA7A7-92BD-4F4A-83CE-DB44CB2FECADQ36243536-7B9AF4CD-4367-493E-B1D1-12C7962A7B6FQ36608571-8C237C8C-D09C-4E43-B061-1B39EDB0A72CQ36626087-681475A1-355A-4952-93D3-60C0307F93C7Q36845824-9AA70BB6-EF38-4003-8779-09C5F69510ABQ37137464-6D796E61-4913-4F08-BCC8-52E8D96E5464Q37604481-B7F5BC54-8613-40F8-8CC2-F70177618532Q37825422-F9FA9664-2406-498E-B2D1-22A4F0A9C868Q38282953-2718B5FB-092B-4C73-85B6-35B6021284C8Q38544772-D4A0FF78-5E6E-431C-BFB5-4798BC848367Q39666393-41B1ED12-B790-440B-8972-A4C39A1B3F4FQ41561252-B984AB74-2CF8-4C30-BAD4-28BF5ECB694EQ51142505-C5E1438D-F25D-4F91-B4FD-F90EFDDD4EF1Q58750585-A5D90DF0-519A-419D-B896-08B6DDCCC7F9
P2860
Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@en
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@nl
type
label
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@en
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@nl
prefLabel
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@en
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@nl
P2093
P921
P356
P1433
P1476
Naked DNA and adenoviral immun ...... : a phase I/II clinical trial.
@en
P2093
D Loukinov
G Georgiev
H T Meryman
I Altankova
M Mincheff
S Tchakarov
P304
P407
P577
2000-08-01T00:00:00Z